These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17908948)

  • 1. In Vitro susceptibility of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus to a new antimicrobial, copper silicate.
    Carson KC; Bartlett JG; Tan TJ; Riley TV
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4505-7. PubMed ID: 17908948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid differentiation of methicillin-susceptible Staphylococcus aureus from methicillin-resistant S. aureus and MIC determinations by isothermal microcalorimetry.
    von Ah U; Wirz D; Daniels AU
    J Clin Microbiol; 2008 Jun; 46(6):2083-7. PubMed ID: 18417657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics of the antibacterial effect and emergence of resistance to tomopenem, formerly RO4908463/CS-023, in an in vitro pharmacokinetic model of Staphylococcus aureus infection.
    MacGowan AP; Bowker KE; Noel AR
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1401-6. PubMed ID: 18227179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections.
    Chusri S; Voravuthikunchai SP
    Phytother Res; 2008 Apr; 22(4):560-2. PubMed ID: 18338770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
    Lemaire S; Olivier A; Van Bambeke F; Tulkens PM; Appelbaum PC; Glupczynski Y
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2797-805. PubMed ID: 18519727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of a bovine myeloid antimicrobial peptide (BMAP-28) against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Takagi S; Hayashi S; Takahashi K; Isogai H; Bai L; Yoneyama H; Ando T; Ito K; Isogai E
    Anim Sci J; 2012 Jun; 83(6):482-6. PubMed ID: 22694332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa.
    Tomozawa T; Sugihara C; Kakuta M; Sugihara K; Koga T
    J Med Microbiol; 2010 Apr; 59(Pt 4):438-441. PubMed ID: 20093378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model.
    Odenholt I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3311-6. PubMed ID: 17620377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion From Methicillin Susceptibility to Methicillin Resistance in Staphylococcus aureus.
    Gelfand MS; Cleveland KO
    J Infect Dis; 2016 May; 213(10):1671. PubMed ID: 26962235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study on the resistance of methicillin-resistant staphylococcus aureus to iodophor and chlorhexidine].
    Zhang YH; Liu XY; Zhu LL; Yu YZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Mar; 25(3):248-50. PubMed ID: 15200941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus.
    Filocamo A; Bisignano C; D'Arrigo M; Ginestra G; Mandalari G; Galati EM
    Lett Appl Microbiol; 2011 Aug; 53(2):193-7. PubMed ID: 21609344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects in vitro of tea tree oil and plaunotol on methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.
    Hada T; Furuse S; Matsumoto Y; Hamashima H; Masuda K; Shiojima K; Arai T; Sasatsu M
    Microbios; 2001; 106 Suppl 2():133-41. PubMed ID: 11548201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus.
    Wu SW; de Lencastre H; Tomasz A
    J Bacteriol; 2001 Apr; 183(8):2417-24. PubMed ID: 11274099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
    Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
    Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of GAR-936 and other antimicrobial agents against North American isolates of Staphylococcus aureus.
    Low DE; Kreiswirth BN; Weiss K; Willey BM
    Int J Antimicrob Agents; 2002 Sep; 20(3):220-2. PubMed ID: 12385702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of phenotypic resistance to ciprofloxacin and levofloxacin in methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains.
    Limoncu MH; Ermertcan S; Cetin CB; Cosar G; Dinç G
    Int J Antimicrob Agents; 2003 May; 21(5):420-4. PubMed ID: 12727074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.
    Suller MT; Russell AD
    J Hosp Infect; 1999 Dec; 43(4):281-91. PubMed ID: 10658804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
    Peterson LR; Cooper I; Willard KE; Fasching CE; Sinn LM; Shanholtzer CJ; Gerding DN
    Chemotherapy; 1994; 40(1):21-5. PubMed ID: 8306811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.